Company: WHWK
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001628280-25-020311
Chunk: 50

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 50
---
 days of April 17, 2025.

(8) Consists of (i) 31,766 shares of common stock held directly by Mr. Giacobello and (ii) 476,140 shares issuable upon the exercise of options within 60 days of April 17, 2025.

(9) Consists of (i) 202,853 shares of common stock held directly by Mr. Ball and (ii) 210,913 shares issuable upon the exercise of options within 60 days of April 17, 2025.

(10) Consists of (i) 1,171,543 shares of common stock held indirectly by the Anishka Family Trust, (ii) 639,698 shares of common stock held indirectly by the Anishka Irrevocable 2016 Trust dated October 19, 2016 (the “Anishka Irrevocable Trust”), and (iii) 464,825 shares of common stock issuable upon the exercise of options within 60 days of April 17, 2025. Dr. Desai disclaims beneficial ownership of the securities held in the Anishka Irrevocable Trust, except to the extent of any pecuniary interest therein.

(11) Consists of (i) 4,294 shares of common stock held indirectly by Dr. Itri; (ii) 372,142 shares of common stock issuable upon the exercise of options within 60 days of April 17, 2025 and (iii) 3,000 shares of common stock held indirectly by Dr. Itri’s spouse.

(12) Consists of (i) 19,694 shares of common stock held directly by Dr. Castelein, (ii) 2,165,998 shares of common stock held indirectly by KVP Capital, LP (“KVP Capital”), and (iii) 117,727 shares of common stock issuable upon the exercise of options within 60 days of April 17, 2025. Dr. Castelein is the Managing Director of KVP Capital and Dr. Castelein disclaims beneficial ownership of the shares held by KVP Capital, except to the extent of his pecuniary interest therein.

(13) Consists of (i) the securities listed in footnote (1) above and (ii) 110,209 shares of common stock issuable upon the exercise of options within 60 days of April 17, 2025